Omega-3 polyunsaturated fatty acids promote amyloid-b clearance from the brain through mediating the function of the glymphatic system

FASEB Journal

Volumn 31, Issue 1, 2017, Pages 282-293

  Ren, Huixia ^a   Luo, Chuanming ^b   Feng, Yanqing ^c   Yao, Xiaoli ^c   Shi, Zhe ^a   Liang, Fengyin ^b   Kang, Jing X ^d   Wan, Jian Bo ^a   Pei, Zhong ^c   Su, Huanxing ^a  

^a University of Macau   (Macao)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

AQP4 polarization; DHA; Extracellular solutes clearance; Fish oil; Perivascular pathways

Indexed keywords

ADRENIC ACID; AMYLOID BETA PROTEIN; AQUAPORIN 4; ARACHIDONIC ACID; DIHOMO GAMMA LINOLENIC ACID; DOCOSAPENTAENOIC ACID; LINOLEIC ACID; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN; BRAIN BLOOD VESSEL; BRAIN CORTEX; BRAIN TISSUE; CELL ACTIVATION; CONTROLLED STUDY; HIPPOCAMPAL CA3 REGION; IMMUNOFLUORESCENCE; MALE; MEMORY; MORRIS WATER MAZE TEST; MOUSE; NEUROPROTECTION; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; SPATIAL LEARNING; TRANSGENIC MOUSE; ANIMAL; GENETICS; METABOLISM; ORAL DRUG ADMINISTRATION; PHYSIOLOGY;

ADMINISTRATION, ORAL; AMYLOID BETA-PEPTIDES; ANIMALS; AQUAPORIN 4; ASTROCYTES; BRAIN; FATTY ACIDS, OMEGA-3; MICE; MICE, TRANSGENIC;

EID: 85009809502     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.201600896     Document Type: Article

References (51)

1. Bazinet, R. P., and Laýe, S. (2014) Polyunsaturated fatty acids and theirmetabolites in brain function and disease. Nat. Rev. Neurosci. 15, 771-785.
2. Barberger-Gateau, P., Letenneur, L., Deschamps, V., Ṕeres, K., Dartigues, J. F., and Renaud, S. (2002) Fish, meat, and risk of dementia: cohort study. BMJ 325, 932-933.
3. Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., Aggarwal, N., and Schneider, J. (2003) Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch. Neurol. 60, 940-946.
4. Chiu, C. C., Su, K. P., Cheng, T. C., Liu, H. C., Chang, C. J., Dewey, M. E., Stewart, R., and Huang, S. Y. (2008) The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 1538-1544.
5. Kotani, S., Sakaguchi, E., Warashina, S., Matsukawa, N., Ishikura, Y., Kiso, Y., Sakakibara, M., Yoshimoto, T., Guo, J., and Yamashima, T. (2006) Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci. Res. 56, 159-164.
6. Lee, L. K., Shahar, S., Chin, A. V., and Yusoff, N. A. (2013) Docosahexaenoic acid-concentrated fish oil supplementation in subjects withmild cognitive impairment(MCI): a 12-monthrandomised, double-blind, placebo-controlled trial. Psychopharmacology (Berl.) 225, 605-612.
7. Van Gelder, B.M., Tijhuis, M., Kalmijn, S., and Kromhout, D. (2007) Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study. Am. J. Clin. Nutr. 85, 1142-1147.
8. Calon, F., Lim, G. P., Yang, F., Morihara, T., Teter, B., Ubeda, O., Rostaing, P., Triller, A., Salem, N. Jr., Ashe, K.H., Frautschy, S. A., and Cole, G. M. (2004) Docosahexaenoic acid protects from dendritic pathology inanAlzheimer's diseasemousemodel. Neuron 43, 633-645.
9. Lim, G. P., Calon, F., Morihara, T., Yang, F., Teter, B., Ubeda, O., Salem, N. Jr., Frautschy, S.A., andCole, G.M. (2005)Adiet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimermousemodel. J. Neurosci. 25, 3032-3040.
10. Green, K. N., Martinez-Coria, H., Khashwji, H., Hall, E. B., Yurko-Mauro, K. A., Ellis, L., and LaFerla, F. M. (2007) Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J. Neurosci. 27, 4385-4395.
11. Oksman, M., Iivonen, H., Hogyes, E., Amtul, Z., Penke, B., Leenders, I., Broersen, L., Lutjohann, D., Hartmann, T., and Tanila, H. (2006) Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol. Dis. 23, 563-572.
12. Broersen, L. M., Kuipers, A. A., Balvers, M., van Wijk, N., Savelkoul, P. J., de Wilde, M.C., van der Beek, E.M., Sijben, J.W., Hageman, R. J., Kamphuis, P. J., and Kiliaan, A. J. (2013) A specificmulti-nutrient diet reduces Alzheimer-like pathology in young adult AbPPswe/PS1dE9 mice. J. Alzheimers Dis. 33, 177-190.
13. Perez, S.E., Berg, B. M., Moore, K.A., He, B., Counts, S. E., Fritz, J. J., Hu, Y. S., Lazarov, O., Lah, J. J., and Mufson, E. J. (2010) DHA diet reduces AD pathology in young APPswe/PS1 Delta E9 transgenic mice: possible gender effects. J. Neurosci. Res. 88, 1026-1040.
14. Grimm, M. O., Kuchenbecker, J., Grosgen, S., Burg, V. K., Hundsdorfer, B., Rothhaar, T. L., Friess, P., de Wilde, M. C., Broersen, L. M., Penke, B., Ṕeter, M., Vigh, L., Grimm, H. S., and Hartmann, T. (2011) Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms. J. Biol. Chem. 286, 14028-14039.
15. Hossain, S., Hashimoto, M., Katakura, M., Miwa, K., Shimada, T., and Shido, O. (2009) Mechanism of docosahexaenoic acid-induced inhibition of in vitro Abeta1-42 fibrillation and Abeta1-42-induced toxicity in SH-S5Y5 cells. J. Neurochem. 111, 568-579.
16. Lukiw, W. J., Cui, J. G., Marcheselli, V. L., Bodker, M., Botkjaer, A., Gotlinger, K., Serhan, C. N., and Bazan, N. G. (2005) A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J. Clin. Invest. 115, 2774-2783.
17. Hardy, J., and Selkoe, D. J. (2002)Theamyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
18. Zlokovic, B.V., Yamada, S., Holtzman, D., Ghiso, J., and Frangione, B. (2000) Clearance of amyloid beta-peptide from brain: transport or metabolism? Nat. Med. 6, 718-719.
19. Potter, R., Patterson, B. W., Elbert, D. L., Ovod, V., Kasten, T., Sigurdson, W., Mawuenyega, K., Blazey, T., Goate, A., Chott, R., Yarasheski, K. E., Holtzman, D.M., Morris, J. C., Benzinger, T. L., and Bateman, R. J. (2013) Increased in vivo amyloid-b42 production, exchange, and loss in presenilin mutation carriers. Sci. Transl.Med. 5, 189ra77.
20. Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., and Bateman, R. J. (2010)Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science 330, 1774.
21. Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., Nagelhus, E. A., and Nedergaard, M. (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid b. Sci. Transl. Med. 4, 147ra111.
22. Iliff, J. J., Chen, M. J., Plog, B. A., Zeppenfeld, D.M., Soltero, M., Yang, L., Singh, I., Deane, R., and Nedergaard, M. (2014) Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J. Neurosci. 34, 16180-16193.
23. Plog, B. A., Dashnaw, M. L., Hitomi, E., Peng, W., Liao, Y., Lou, N., Deane, R., and Nedergaard, M. (2015)Biomarkers of traumatic injury are transported from brain to blood via the glymphatic system. J. Neurosci. 35, 518-526.
24. Kang, J. X., Wang, J., Wu, L., and Kang, Z. B. (2004)Transgenicmice: fat-1 mice convert n-6 to n-3 fatty acids. Nature 427, 504.
25. Luo, C., Ren, H., Wan, J. B., Yao, X., Zhang, X., He, C., So, K. F., Kang, J. X., Pei, Z., and Su, H. (2014) Enriched endogenous omega-3 fatty acids in mice protect against global ischemia injury. J. Lipid Res. 55, 1288-1297.
26. Iliff, J. J., Wang, M., Zeppenfeld, D.M., Venkataraman, A., Plog, B. A., Liao, Y., Deane, R., and Nedergaard, M. (2013) Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain. J. Neurosci. 33, 18190-18199.
27. Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O'Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., Takano, T., Deane, R., and Nedergaard, M. (2013) Sleep drives metabolite clearance from the adult brain. Science 342, 373-377.
28. Shih, A. Y., Driscoll, J. D., Drew, P. J., Nishimura, N., Schaffer, C. B., and Kleinfeld, D. (2012) Two-photon microscopy as a tool to study blood flow and neurovascular coupling in the rodent brain [published erratum in: J. Cereb. Blood Flow Metab. (2013) 2, 319]. J. Cereb. Blood Flow Metab. 32, 1277-1309.
29. Brouillette, J., Caillierez, R., Zommer, N., Alves-Pires, C., Benilova, I., Blum, D., De Strooper, B., and Búee, L. (2012) Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloidb1- 42 oligomers are revealed in vivo by using a novel animal model. J. Neurosci. 32, 7852-7861.
30. Chung, K., and Deisseroth, K. (2013) CLARITY for mapping the nervous system. Nat. Methods 10, 508-513.
31. Willard, A. M., and Gittis, A. H. (2015) Mapping neural circuits with CLARITY. eLife 4, e11409.
32. Zheng, H., and Rinaman, L. (2016) Simplified CLARITY for visualizing immunofluorescence labeling in the developing rat brain. Brain Struct. Funct. 221, 2375-2383.
33. Ledo, J. H., Azevedo, E. P., Clarke, J. R., Ribeiro, F. C., Figueiredo, C. P., Foguel, D., De Felice, F.G., and Ferreira, S. T. (2013) Amyloid-b oligomers link depressive-like behavior and cognitive deficits in mice. Mol. Psychiatry 18, 1053-1054.
34. Russo, I., Caracciolo, L., Tweedie, D., Choi, S. H., Greig, N. H., Barlati, S., and Bosetti, F. (2012) 3, 69-Dithiothalidomide, a new TNF-a synthesis inhibitor, attenuates the effect of Ab1-42intracerebroventricular injection on hippocampal neurogenesis and memory deficit. J. Neurochem. 122, 1181-1192.
35. Marteinsdottir, I., Horrobin, D. F., Stenfors, C., Theodorsson, E., and Mathe, A. A. (1998) Changes in dietary fatty acids alter phospholipid fatty acid composition in selected regions of rat brain. Prog. Neuropsychopharmacol. Biol. Psychiatry 22, 1007-1021.
36. Ren, Z., Iliff, J. J., Yang, L., Yang, J., Chen, X., Chen, M. J., Giese, R.N., Wang, B., Shi, X., andNedergaard, M. (2013) 'Hit & Run' model of closed-skull traumatic brain injury (TBI) reveals complex patterns of post-traumatic AQP4 dysregulation. J. Cereb. Blood Flow Metab. 33, 834-845.
37. Kress, B. T., Iliff, J. J., Xia, M., Wang, M., Wei, H. S., Zeppenfeld, D., Xie, L., Kang, H., Xu, Q., Liew, J. A., Plog, B. A., Ding, F., Deane, R., and Nedergaard, M. (2014) Impairment of paravascular clearance pathways in the aging brain. Ann. Neurol. 76, 845-861.
38. Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D.M., Miller, C. A., Strickland, D. K., Ghiso, J., and Zlokovic, B. V. (2000) Clearance of Alzheimer's amyloid-ss (1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106, 1489-1499.
39. Zlokovic, B. V., Deane, R., Sagare, A. P., Bell, R. D., and Winkler, E. A. (2010) Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid b-peptide elimination from the brain. J. Neurochem. 115, 1077-1089.
40. Guemez-Gamboa, A., Nguyen, L. N., Yang, H., Zaki, M. S., Kara, M., Ben-Omran, T., Akizu, N., Rosti, R. O., Rosti, B., Scott, E., Schroth, J., Copeland, B., Vaux, K. K., Cazenave-Gassiot, A., Quek, D. Q., Wong, B.H., Tan, B.C., Wenk, M. R., Gunel, M., Gabriel, S., Chi, N. C., Silver, D. L., and Gleeson, J. G. (2015) Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome. Nat. Genet. 47, 809-813.
41. Mukherjee, P. K., Marcheselli, V. L., Serhan, C. N., and Bazan, N. G. (2004) Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells fromoxidative stress. Proc. Natl. Acad. Sci. USA 101, 8491-8496.
42. Kim, H. Y., Akbar, M., Lau, A., and Edsall, L. (2000) Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect. J. Biol. Chem. 275, 35215-35223.
43. Rashid, M.A., Katakura, M., Kharebava, G., Kevala, K., and Kim, H. Y. (2013) N-Docosahexaenoylethanolamine is a potent neurogenic factor for neural stem cell differentiation. J. Neurochem. 125, 869-884.
44. He, C., Qu, X., Cui, L., Wang, J., and Kang, J. X. (2009) Improved spatial learningperformance of fat-1mice is associatedwithenhanced neurogenesis and neuritogenesis by docosahexaenoic acid. Proc.Natl. Acad. Sci. USA 106, 11370-11375.
45. Orr, S. K., and Bazinet, R. P. (2008) The emerging role of docosahexaenoic acid in neuroinflammation. Curr. Opin. Investig. Drugs 9, 735-743.
46. Kalmijn, S., Launer, L. J., Ott, A., Witteman, J. C., Hofman, A., and Breteler, M. M. (1997) Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann. Neurol. 42, 776-782.
47. Barberger-Gateau, P., Raffaitin, C., Letenneur, L., Berr, C., Tzourio, C., Dartigues, J. F., and Alṕerovitch, A. (2007) Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 69, 1921-1930.
48. Morris, M. C., Evans, D. A., Tangney, C. C., Bienias, J. L., and Wilson, R. S. (2005) Fish consumption and cognitive decline with age in a large community study. Arch. Neurol. 62, 1849-1853.
49. Thal, D. R., Griffin, W. S., and Braak, H. (2008) Parenchymal and vascular Abeta-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease. J. Cell. Mol. Med. 12 (5), 1848-1862.
50. Arsenault, D., Julien, C., Tremblay, C., and Calon, F. (2011) DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice. PLoS One 6, e17397.
51. Nielsen, S., Nagelhus, E. A., Amiry-Moghaddam, M., Bourque, C., Agre, P., and Ottersen, O. P. (1997) Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J. Neurosci. 17, 171-180.